SK284581B6 - Použitie levosimendanu alebo jeho farmaceuticky prijateľnej soli na výrobu liečiva na liečenie pľúcnej hypertenzie - Google Patents

Použitie levosimendanu alebo jeho farmaceuticky prijateľnej soli na výrobu liečiva na liečenie pľúcnej hypertenzie Download PDF

Info

Publication number
SK284581B6
SK284581B6 SK1925-2000A SK19252000A SK284581B6 SK 284581 B6 SK284581 B6 SK 284581B6 SK 19252000 A SK19252000 A SK 19252000A SK 284581 B6 SK284581 B6 SK 284581B6
Authority
SK
Slovakia
Prior art keywords
levosimendan
treatment
pulmonary hypertension
medicament
pharmaceutically acceptable
Prior art date
Application number
SK1925-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK19252000A3 (sk
Inventor
Lasse Lehtonen
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of SK19252000A3 publication Critical patent/SK19252000A3/sk
Publication of SK284581B6 publication Critical patent/SK284581B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SK1925-2000A 1998-06-25 1999-06-18 Použitie levosimendanu alebo jeho farmaceuticky prijateľnej soli na výrobu liečiva na liečenie pľúcnej hypertenzie SK284581B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981473A FI981473A (fi) 1998-06-25 1998-06-25 Menetelmä pulmonaalihypertension hoitamiseksi
PCT/FI1999/000540 WO1999066912A2 (en) 1998-06-25 1999-06-18 Method of treating pulmonary hypertension

Publications (2)

Publication Number Publication Date
SK19252000A3 SK19252000A3 (sk) 2002-04-04
SK284581B6 true SK284581B6 (sk) 2005-07-01

Family

ID=8552079

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1925-2000A SK284581B6 (sk) 1998-06-25 1999-06-18 Použitie levosimendanu alebo jeho farmaceuticky prijateľnej soli na výrobu liečiva na liečenie pľúcnej hypertenzie

Country Status (24)

Country Link
US (1) US6462045B1 (fi)
EP (1) EP1089737B1 (fi)
JP (1) JP4536922B2 (fi)
KR (1) KR100661769B1 (fi)
AT (1) ATE226076T1 (fi)
AU (1) AU748883B2 (fi)
BR (1) BR9911422A (fi)
CA (1) CA2335280C (fi)
CZ (1) CZ300844B6 (fi)
DE (1) DE69903546T2 (fi)
DK (1) DK1089737T3 (fi)
EA (1) EA003055B1 (fi)
EE (1) EE04355B1 (fi)
ES (1) ES2186375T3 (fi)
FI (1) FI981473A (fi)
HU (1) HU226021B1 (fi)
MX (1) MXPA00012618A (fi)
NO (1) NO317593B1 (fi)
NZ (1) NZ508833A (fi)
PL (1) PL193055B1 (fi)
PT (1) PT1089737E (fi)
SK (1) SK284581B6 (fi)
WO (1) WO1999066912A2 (fi)
ZA (1) ZA200007462B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20001542A (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
WO2006087420A2 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
RO113612B1 (ro) * 1991-04-17 1998-09-30 Merck & Co Inc Compozitie oftalmica
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
EE200000775A (et) 2002-04-15
NO317593B1 (no) 2004-11-15
JP2002518436A (ja) 2002-06-25
DE69903546T2 (de) 2003-06-18
BR9911422A (pt) 2001-03-13
EA003055B1 (ru) 2002-12-26
AU748883B2 (en) 2002-06-13
ZA200007462B (en) 2002-03-13
CA2335280A1 (en) 1999-12-29
KR20010072640A (ko) 2001-07-31
DE69903546D1 (de) 2002-11-21
HUP0102929A2 (hu) 2002-04-29
HU226021B1 (en) 2008-03-28
FI981473A (fi) 1999-12-26
DK1089737T3 (da) 2003-02-10
NO20006652D0 (no) 2000-12-22
MXPA00012618A (es) 2005-06-06
FI981473A0 (fi) 1998-06-25
PL193055B1 (pl) 2007-01-31
EE04355B1 (et) 2004-10-15
NZ508833A (en) 2002-10-25
PL345467A1 (en) 2001-12-17
US6462045B1 (en) 2002-10-08
ATE226076T1 (de) 2002-11-15
CA2335280C (en) 2007-10-30
SK19252000A3 (sk) 2002-04-04
HUP0102929A3 (en) 2002-07-29
ES2186375T3 (es) 2003-05-01
EA200100074A1 (ru) 2001-06-25
JP4536922B2 (ja) 2010-09-01
NO20006652L (no) 2000-12-22
EP1089737B1 (en) 2002-10-16
KR100661769B1 (ko) 2006-12-28
EP1089737A2 (en) 2001-04-11
AU4786499A (en) 2000-01-10
CZ20004663A3 (en) 2001-05-16
WO1999066912A2 (en) 1999-12-29
PT1089737E (pt) 2003-03-31
WO1999066912A3 (en) 2000-03-16
CZ300844B6 (cs) 2009-08-26

Similar Documents

Publication Publication Date Title
SK284581B6 (sk) Použitie levosimendanu alebo jeho farmaceuticky prijateľnej soli na výrobu liečiva na liečenie pľúcnej hypertenzie
EP1408977B1 (en) A combination therapy for the treatment of heart failure
EP1191935B1 (en) Treatment or prevention of coronary graft vasospasm
EP1581227B1 (en) A method for treating renal failure
US20040180895A1 (en) Use of a pyridazinone derivative
US7485642B2 (en) Method for treating septic shock
CA2387920C (en) A new use of levosimendan
JP2003512328A5 (fi)

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130618